NASDAQ:CYRX Cryoport (CYRX) Stock Forecast, Price & News $18.67 -0.40 (-2.10%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$18.54▼$19.4150-Day Range$18.67▼$24.0052-Week Range$15.63▼$45.36Volume259,992 shsAverage Volume356,003 shsMarket Capitalization$850.23 millionP/E RatioN/ADividend YieldN/APrice Target$29.50 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Cryoport MarketRank™ ForecastAnalyst RatingBuy3.00 Rating ScoreUpside/Downside58.0% Upside$29.50 Price TargetShort InterestBearish8.22% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.33Based on 5 Articles This WeekInsider TradingSelling Shares$3.88 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.64) to ($0.42) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.07 out of 5 starsTransportation Sector80th out of 124 stocksPharmaceutical Preparations Industry269th out of 498 stocks 3.5 Analyst's Opinion Consensus RatingCryoport has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $29.50, Cryoport has a forecasted upside of 58.0% from its current price of $18.67.Amount of Analyst CoverageCryoport has only been the subject of 1 research reports in the past 90 days. Previous Next 0.0 Short Interest Percentage of Shares Shorted8.22% of the float of Cryoport has been sold short.Short Interest Ratio / Days to CoverCryoport has a short interest ratio ("days to cover") of 10, which indicates bearish sentiment.Change versus previous month Previous Next 0.0 Dividend Strength Dividend YieldCryoport does not currently pay a dividend.Dividend GrowthCryoport does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CYRX. Previous Next 3.5 News and Social Media Coverage News SentimentCryoport has a news sentiment score of 1.33. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Transportation companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Cryoport this week, compared to 2 articles on an average week.Search Interest1 people have searched for CYRX on MarketBeat in the last 30 days. MarketBeat FollowsOnly 1 people have added Cryoport to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cryoport insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,879,341.00 in company stock.Percentage Held by Insiders10.50% of the stock of Cryoport is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions88.66% of the stock of Cryoport is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cryoport are expected to grow in the coming year, from ($0.64) to ($0.42) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cryoport is -23.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cryoport is -23.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCryoport has a P/B Ratio of 1.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cryoport (NASDAQ:CYRX) StockCryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.Read More Receive CYRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter. Email Address CYRX Stock News HeadlinesMay 26, 2023 | americanbankingnews.comCryoport (NASDAQ:CYRX) Shares Down 7.4% May 25, 2023 | finance.yahoo.comCryoPort (CYRX) Rose on Revenue GuidanceMay 27, 2023 | Stocks To Trade (Ad)15 A.I. Trading Opportunities a DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 17, 2023 | marketwatch.com8-K: Cryoport, Inc.May 17, 2023 | msn.comLooking Into CryoPort's Return On Invested CapitalMay 15, 2023 | americanbankingnews.comInsider Selling: Cryoport, Inc. (NASDAQ:CYRX) CFO Sells $437,000.92 in StockMay 15, 2023 | americanbankingnews.comInsider Selling: Cryoport, Inc. (NASDAQ:CYRX) Director Sells $154,936.53 in StockMay 15, 2023 | americanbankingnews.comInsider Selling: Cryoport, Inc. (NASDAQ:CYRX) CEO Sells $3,053,269.17 in StockMay 27, 2023 | Stocks To Trade (Ad)15 A.I. Trading Opportunities a DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 12, 2023 | finance.yahoo.comCryoport, Inc. (NASDAQ:CYRX) Screens Well But There Might Be A CatchMay 4, 2023 | finance.yahoo.comCryoport Reports First Quarter 2023 ResultsApril 27, 2023 | finance.yahoo.comWill CryoPort, Inc. (CYRX) Report Negative Q1 Earnings? What You Should KnowApril 27, 2023 | finance.yahoo.comCryoport to Report First Quarter 2023 Financial Results on May 4, 2023April 25, 2023 | finance.yahoo.comCryoport Signs New Supply Chain Solutions Agreement with Boston IVF to Support Reproductive Material Shipments Across the U.S.April 24, 2023 | americanbankingnews.comCryoport (NASDAQ:CYRX) Given "Buy" Rating at Needham & Company LLCApril 23, 2023 | americanbankingnews.comHead to Head Review: Cryoport (NASDAQ:CYRX) vs. Pasithea Therapeutics (NASDAQ:KTTA)April 7, 2023 | americanbankingnews.comAnalysts Issue Forecasts for Cryoport, Inc.'s Q1 2023 Earnings (NASDAQ:CYRX)April 1, 2023 | finance.yahoo.comCryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 94% Above Its Share PriceMarch 26, 2023 | americanbankingnews.comCryoport (NASDAQ:CYRX) Share Price Crosses Above 200-Day Moving Average of $22.26March 16, 2023 | finance.yahoo.comMacroeconomic Headwinds Dragged Cryoport (CYRX) in Q4March 13, 2023 | finance.yahoo.comCryoport Confirms No Financial Exposure to Silicon Valley BankFebruary 23, 2023 | finance.yahoo.comCryoport Reports Fourth Quarter and Full Year 2022 ResultsFebruary 15, 2023 | finance.yahoo.comCryoport to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023February 8, 2023 | seekingalpha.comCryoport: Differentiated Offering In The Life Sciences Value ChainJanuary 29, 2023 | finance.yahoo.comWhen Will Cryoport, Inc. (NASDAQ:CYRX) Become Profitable?January 18, 2023 | finance.yahoo.comCryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene TherapiesDecember 23, 2022 | seekingalpha.comMadrigal Pharmaceuticals: Upcoming Windfall ProfitsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive CYRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryoport and its competitors with MarketBeat's FREE daily newsletter. Email Address CYRX Company Calendar Last Earnings5/04/2023Today5/27/2023Next Earnings (Estimated)8/03/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorTransportation Current SymbolNASDAQ:CYRX CUSIPN/A CIK1124524 Webwww.cryoport.com Phone(949) 470-2300Fax949-470-2306Employees1,024Year FoundedN/APrice Target and Rating Average Stock Price Forecast$29.50 High Stock Price Forecast$30.00 Low Stock Price Forecast$28.00 Forecasted Upside/Downside+58.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.78) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-37,330,000.00 Net Margins-11.91% Pretax Margin-10.94% Return on Equity-4.90% Return on Assets-2.55% Debt Debt-to-Equity Ratio0.76 Current Ratio14.54 Quick Ratio13.90 Sales & Book Value Annual Sales$237.28 million Price / Sales3.58 Cash FlowN/A Price / Cash FlowN/A Book Value$11.86 per share Price / Book1.57Miscellaneous Outstanding Shares45,540,000Free Float40,763,000Market Cap$850.23 million OptionableOptionable Beta1.32 Key ExecutivesJerrell W. SheltonChairman, President & Chief Executive OfficerRobert S. StefanovichChief Financial Officer, Secretary & TreasurerMark W. SawickiChief Scientific OfficerThomas J. HeinzenVice President-Corporate DevelopmentKey CompetitorsDorian LPGNYSE:LPGGreenbrier CompaniesNYSE:GBXSun Country AirlinesNASDAQ:SNCYCostamareNYSE:CMRENordic American TankersNYSE:NATView All CompetitorsInsiders & InstitutionsRoyce & Associates LPSold 14,000 shares on 5/23/2023Ownership: 0.075%Ameriprise Financial Inc.Bought 157,364 shares on 5/22/2023Ownership: 0.432%JPMorgan Chase & Co.Bought 10,933 shares on 5/18/2023Ownership: 0.132%Chevy Chase Trust Holdings LLCSold 80,977 shares on 5/17/2023Ownership: 2.573%Jane Street Group LLCSold 8,600 shares on 5/16/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions CYRX Stock - Frequently Asked Questions Should I buy or sell Cryoport stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cryoport in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CYRX shares. View CYRX analyst ratings or view top-rated stocks. What is Cryoport's stock price forecast for 2023? 4 equities research analysts have issued 1 year price objectives for Cryoport's shares. Their CYRX share price forecasts range from $28.00 to $30.00. On average, they expect the company's share price to reach $29.50 in the next twelve months. This suggests a possible upside of 58.0% from the stock's current price. View analysts price targets for CYRX or view top-rated stocks among Wall Street analysts. How have CYRX shares performed in 2023? Cryoport's stock was trading at $17.35 at the beginning of 2023. Since then, CYRX shares have increased by 7.6% and is now trading at $18.67. View the best growth stocks for 2023 here. When is Cryoport's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023. View our CYRX earnings forecast. How were Cryoport's earnings last quarter? Cryoport, Inc. (NASDAQ:CYRX) issued its quarterly earnings data on Thursday, May, 4th. The consumer goods maker reported ($0.16) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.02. The consumer goods maker had revenue of $62.82 million for the quarter, compared to analyst estimates of $62.15 million. Cryoport had a negative net margin of 11.91% and a negative trailing twelve-month return on equity of 4.90%. The business's revenue was up 20.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.31) earnings per share. What ETFs hold Cryoport's stock? ETFs with the largest weight of Cryoport (NASDAQ:CYRX) stock in their portfolio include Principal Healthcare Innovators ETF (BTEC), Pacer Industrials and Logistics ETF (SHPP), What guidance has Cryoport issued on next quarter's earnings? Cryoport issued an update on its FY 2023 earnings guidance on Thursday, May, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $270.00 million-$290.00 million, compared to the consensus revenue estimate of $273.56 million. What other stocks do shareholders of Cryoport own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cryoport investors own include Gilead Sciences (GILD), Advanced Micro Devices (AMD), Micron Technology (MU), NVIDIA (NVDA), Taiwan Semiconductor Manufacturing (TSM), Amarin (AMRN), QUALCOMM (QCOM), Enterprise Products Partners (EPD), Pfizer (PFE) and Block (SQ). What is Cryoport's stock symbol? Cryoport trades on the NASDAQ under the ticker symbol "CYRX." Who are Cryoport's major shareholders? Cryoport's stock is owned by many different retail and institutional investors. Top institutional investors include Brown Capital Management LLC (16.44%), BlackRock Inc. (6.96%), Impax Asset Management Group plc (5.54%), Fred Alger Management LLC (5.30%), Macquarie Group Ltd. (3.08%) and Clearbridge Investments LLC (2.76%). Insiders that own company stock include Daniel M Hancock, Daniel M Hancock, Edward J Zecchini, Freeze Parent LP Blackstone, Jerrell Shelton, Mark W Sawicki, Michael R Egeck, Richard J Berman, Robert J Hariri and Robert Stefanovich. View institutional ownership trends. How do I buy shares of Cryoport? Shares of CYRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cryoport's stock price today? One share of CYRX stock can currently be purchased for approximately $18.67. How much money does Cryoport make? Cryoport (NASDAQ:CYRX) has a market capitalization of $850.23 million and generates $237.28 million in revenue each year. The consumer goods maker earns $-37,330,000.00 in net income (profit) each year or ($0.78) on an earnings per share basis. How many employees does Cryoport have? The company employs 1,024 workers across the globe. How can I contact Cryoport? Cryoport's mailing address is 112 Westwood Place Suite 350, Brentwood TN, 37027. The official website for the company is www.cryoport.com. The consumer goods maker can be reached via phone at (949) 470-2300, via email at tfromer@kcsa.com, or via fax at 949-470-2306. This page (NASDAQ:CYRX) was last updated on 5/27/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryoport, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.